Back to Trades
Other4
Emergent BioSolutions Inc.
EBS
Total Value
$346.2K
Company Information
- Company Name
- Emergent BioSolutions Inc.
- Ticker Symbol
- EBS
- CIK
- 0001367644
Insider Information
- Name
- Glessner Coleen
- Role
- EVP, Quality & Ethics, and CPL
- Location
- GAITHERSBURG, MD
Officer
Filing Details
- Filing Date
- Feb 10, 2026
- Transaction Date
- Feb 6, 2026
- Accession Number
- 0001919170-26-000003
- Form Type
- 4
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Feb 6, 2026 | Common Stock | 28,847 | $10.92 | Disposition | $315.0K |
| Feb 6, 2026 | Common Stock | 2,852 | $10.92 | Tax Withholding | $31.1K |
Footnotes
- (F1)Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to both cumulative revenues and adjusted EBITDA as a percentage of total GAAP revenue calculated on a cumulative basis over the three-year period beginning January 1, 2023 and ending December 31, 2025. On February 06, 2026, the final certification date, the Compensation Committee certified the achievement of the 2023-2025 PSUs at a payout factor of 25% of target resulting in the actual award of 9,615 shares of common stock, which is less than the 38,462 shares previously reported on March 02, 2023 and June 09, 2023.
- (F2)Represents shares of common stock withheld to pay taxes associated with vesting and settlement of restricted stock units